Search Results - "Popmihajlov, Z"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice by Shear, N.H., Hartmann, M., Toledo-Bahena, M., Katsambas, A., Connors, L., Chang, Q., Yao, R., Nograles, K., Popmihajlov, Z.

    Published in British journal of dermatology (1951) (01-09-2014)
    “…Summary Background Tumour necrosis factor‐α inhibitors, including infliximab (IFX), can improve disease control of plaque‐type psoriasis. Objectives The…”
    Get full text
    Journal Article
  2. 2

    Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice by Shear, N. H., Hartmann, M., Toledo-Bahena, M. E., Gilbert, M., Katsambas, A., Yao, R., Popmihajlov, Z.

    Published in Quality of life research (01-08-2016)
    “…Purpose We evaluated the effect of plaque-type psoriasis on health-related quality of life (HRQoL) of patients who received infliximab (IFX) in real-world…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    ZOSTER VACCINE LIVE: REVIEW OF POSTMARKETING SAFETY BY DECADE OF LIFE by Willis, E., Woodward, M., Brown, E., Popmihajlov, Z.

    Published in Innovation in aging (01-07-2017)
    “…Zoster Vaccine Live (ZVL) was approved in 2006 for the prevention of herpes zoster (HZ) and post herpetic neuralgia in individuals ≥ 50 years-of-age. To…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial by Peloso, Paul M., Moore, R. Andrew, Chen, Wen-Jer, Lin, Hsiao-Yi, Gates, Davis F., Straus, Walter L., Popmihajlov, Zoran

    Published in Scandinavian journal of pain (01-10-2016)
    “…Highlights • Better functional responses were more likely in patients with better pain response. • Better QoL improvements were more likely in patients with…”
    Get full text
    Journal Article
  11. 11

    Association of beta sub(2)-microglobulin with the alpha sub(3) domain of H-2D super(b) heavy chain by Lili, M, Popmihajlov, Z, Monaco, J J, Vukmanovi, S

    Published in Immunogenetics (New York) (01-02-2004)
    “…MHC class I molecules are heterotrimeric complexes composed of heavy chain, beta sub(2)-microglobulin ( beta sub(2)m) and short peptide. This trimeric complex…”
    Get full text
    Journal Article